Factors influencing adherence in children and adolescents treated with antipsychotics or antidepressants.
作者信息
Yazdi Kurosch, Unterlass Gabriele, Kemmler Georg, Kralovec Karl, Aichhorn Wolfgang
出版信息
Prim Care Companion J Clin Psychiatry. 2008;10(2):160-1. doi: 10.4088/pcc.v10n0213a.
Abstract
摘要
相似文献
1
Factors influencing adherence in children and adolescents treated with antipsychotics or antidepressants.影响接受抗精神病药物或抗抑郁药物治疗的儿童和青少年依从性的因素。
Prim Care Companion J Clin Psychiatry. 2008;10(2):160-1. doi: 10.4088/pcc.v10n0213a.
2
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.80种抗抑郁药、抗精神病药、抗注意力缺陷/多动障碍药物及心境稳定剂在患有精神疾病的儿童和青少年中的安全性：对78种不良反应的大规模系统性荟萃综述
World Psychiatry. 2020 Jun;19(2):214-232. doi: 10.1002/wps.20765.
3
Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.抗抑郁药可用于治疗精神分裂症前驱期吗？一项针对青少年的前瞻性自然主义治疗研究结果。
J Clin Psychiatry. 2007 Apr;68(4):546-57. doi: 10.4088/jcp.v68n0410.
4
Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark.丹麦儿童和青少年精神药物配药处方的全国性时间趋势。
Acta Psychiatr Scand. 2014 Mar;129(3):221-31. doi: 10.1111/acps.12155. Epub 2013 Jun 6.
5
Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.非典型抗精神病药物治疗儿童和青少年精神分裂症及共病的获益-风险评估
Drug Saf. 2004;27(14):1135-56. doi: 10.2165/00002018-200427140-00005.
6
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence.儿童和青少年精神病学中的抗精神病药物处方：指南遵守情况。
Eur Child Adolesc Psychiatry. 2020 Dec;29(12):1717-1727. doi: 10.1007/s00787-020-01488-6. Epub 2020 Feb 12.
7
Prescribing Pattern of Antidepressants in Children and Adolescents: Findings from the Research on Asia Psychotropic Prescription Pattern.儿童和青少年抗抑郁药的处方模式：亚洲精神药物处方模式研究的结果
East Asian Arch Psychiatry. 2016 Mar;26(1):10-7.
8
Factors That Predict the Use of Psychotropics Among Children and Adolescents With PTSD: Evidence From Private Insurance Claims.预测 PTSD 儿童和青少年使用精神药物的因素：私人保险索赔证据。
Psychiatr Serv. 2018 Sep 1;69(9):1007-1014. doi: 10.1176/appi.ps.201700167. Epub 2018 Jul 2.
9
Second-Generation Antipsychotic Drugs for Children and Adolescents.第二代抗精神病药物在儿童和青少年中的应用。
J Nippon Med Sch. 2021 Mar 11;88(1):10-16. doi: 10.1272/jnms.JNMS.2021_88-108. Epub 2020 Sep 30.
10
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia.痴呆症和疼痛的行为和心理症状的治疗模式：来自大型真实世界样本和认知障碍及痴呆症中心的药物使用证据。
Eur J Clin Pharmacol. 2021 Feb;77(2):241-249. doi: 10.1007/s00228-020-02995-w. Epub 2020 Sep 15.
引用本文的文献
1
A brief motivational intervention for enhancing medication adherence for adolescents with bipolar disorder: A pilot randomized trial.简短动机干预对提高双相情感障碍青少年用药依从性的效果：一项先导随机试验。
J Affect Disord. 2020 Mar 15;265:1-9. doi: 10.1016/j.jad.2020.01.015. Epub 2020 Jan 7.
2
Medication Adherence Among Adolescents with Bipolar Disorder.双相情感障碍青少年的药物依从性
J Child Adolesc Psychopharmacol. 2016 Dec;26(10):864-872. doi: 10.1089/cap.2016.0030. Epub 2016 Jul 15.
本文引用的文献
1
Predictors of health-related quality of life in obese youth.肥胖青少年健康相关生活质量的预测因素。
Obesity (Silver Spring). 2006 Jan;14(1):122-30. doi: 10.1038/oby.2006.15.
2
Psychoactive drug prescribing by Dutch child and adolescent psychiatrists.荷兰儿童及青少年精神科医生开具精神活性药物的情况。
Acta Paediatr. 2005 Oct;94(10):1484-7. doi: 10.1111/j.1651-2227.2005.tb01824.x.
3
Is obesity stigmatizing? Body weight, perceived discrimination, and psychological well-being in the United States.肥胖会带来污名化吗？美国的体重、感知到的歧视与心理健康。
J Health Soc Behav. 2005 Sep;46(3):244-59. doi: 10.1177/002214650504600303.
4
Health-related quality of life in overweight and nonoverweight black and white adolescents.超重及非超重的黑人和白人青少年的健康相关生活质量
J Pediatr. 2005 Oct;147(4):443-50. doi: 10.1016/j.jpeds.2005.05.039.
5
Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?新型抗精神病药物与儿童及青少年肥胖。我们应如何评估药物相关的体重增加？
Acta Psychiatr Scand. 2005 Mar;111(3):177-84. doi: 10.1111/j.1600-0447.2004.00444.x.
6
Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.精神分裂症中的依从性：精神病理学、副作用以及患者对疾病和药物治疗的态度
J Clin Psychiatry. 2004 Sep;65(9):1211-8. doi: 10.4088/jcp.v65n0908.
7
Atypical antipsychotic use in a state hospital inpatient adolescent population.州立医院住院青少年人群中使用非典型抗精神病药物的情况。
J Child Adolesc Psychopharmacol. 2004 Spring;14(1):75-85. doi: 10.1089/104454604773840517.
8
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.非典型抗精神病药物在儿童和青少年治疗中的临床应用
J Clin Psychiatry. 2004;65 Suppl 6:30-44.
9
Factors influencing compliance in schizophrenia patients.影响精神分裂症患者依从性的因素。
J Clin Psychiatry. 2003;64 Suppl 16:10-3.
Zotero 插件